Wirken die Impfungen auch bei schwacher Abwehr?

Die Paper zu dieser Podcast-Folge:

Immunreaktionen von Krebs-Patienten:

• Erin Bange et al, Nature Medicine, 2021 "CD8+ T cells contribute to survival in patients with COVID-19 and hematologic cancer"

• Tatjana Bilich et al, Cancer Discovery, 2021 "Preexisting and post-COVID-19 immune responses to SARS-CoV-2 in cancer patients"

• Amir Massaweh et al, Jama Oncology, 2021 "Evaluation of Seropositivity Following BNT162b2 Messenger RNA Vaccination for SARS-CoV-2 in Patients Undergoing Treatment for Cancer"

• Lova Sun et al, Jama Oncology, 2021 "Immune Responses to SARS-CoV-2 Among Patients With Cancer"

Impfantwort bei Organtransplantierten

• Olivier Marion et al, Annals of Internal Medicine, 2021 "Safety and Immunogenicity of Anti–SARS-CoV-2 Messenger RNA Vaccines in Recipients of Solid Organ Transplants"

Impfbereitschaft bei Autoimmun-Leiden

• Laura Boekel et al, Lancet Rheumatology, 2021 "Perspective of patients with autoimmune diseases on COVID-19 vaccination"